On January 19, 2021, Mediwelcome Medical Technology Co., Ltd. ("Mediwelcome") (stock code: 2159.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. CEB International acted as the Sole Sponsor, Sole Global Coordinator, Joint Bookrunner and Joint Lead Manager for the successful IPO of Mediwelcome. This issuance has been enthusiastically sought after by investors in the capital market. The Hong Kong public offering has received more than 92,000 applications, and was oversubscribed by 167.75 times. The margin amount exceeded HK$3.4 billion.
CEB International, as the sole sponsor for the listing of Mediwelcome, has played a pivotal role in the implementation of this project's sponsorship, market promotion, and regulatory communication by utilizing its professional services and vast resources in the Hong Kong capital market. Despite the many unprecedented challenges encountered during the pandemic, CEB International’s team led the intermediary agencies to overcome the difficulties, and assisted clients to pass the hearing smoothly in mid-December. The overall market promotion was completed in a short period, CEBI’s professional and efficient investment banking services were highly praised by clients and intermediary colleagues.
At the end of December 2020, the Hong Kong market reached another boom in IPO, and 11 IPOs were being offered at the same time. In the face of fierce market competition, CEB International remained organized and calmly faced the challenge. Through active and effective promotion strategies, a strong order demand foundation was built which strengthened its later sales momentum for the successful IPO of Mediwelcome. The outstanding performance by CEB International team drove the enthusiastic subscription atmosphere for Mediwelcome in the capital market, and finally achieved over 100 times of oversubscription, assisting clients in successfully completing this issuance.
As an international investment banking platform wholly-owned by China Everbright Bank in Hong Kong, CEB International has been paying close attention to and serving China's new economy, and is committed to becoming a bridge connecting China's leading enterprises with the international capital market, which will help more high-quality Chinese enterprises develop further and bloom. The successful listing of Mediwelcome reflects the result of CEBI's hard work in the field of innovative medical services. Relying on diversified business products and abundant customer resources, CEB International will continue to provide Chinese companies with a full range of high-quality financial services including sponsorship and underwriting, investment advisory, and asset management to help China's new economy leading companies develop and grow.